• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Inc LXRX 4 Star

Last Price$12.69Day Change (%)4.62%
Open Price$12.05Day Change ($)0.56
Day Range11.92–12.7052-Week Range5.60–13.88

As of Fri 8/28/2015 5:00:00 PM | USD

  1. All
  2. 3rd Party
  1. Ipsen’s Partner, Lexicon Pharmaceuticals , Announces Positive Results from TELESTAR Phase 3 Study Showing That Telotristat Etiprate is Effective in the Treatment of Carcinoid Syndrome Caused by ...

    Ipsen’s Partner, Lexicon Pharmaceuticals , Announces Positive Results from TELESTAR Phase 3 Study Showing That Telotristat Etiprate is Effective in the Treatment of Carcinoid Syndrome Caused by Neuroendocrine Tumors Not Adequately Controlled by Somatostatin ...

  2. Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update

    Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update

  3. Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome

    Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome

  4. Lexicon To Present At The 2015 Wedbush PacGrow Healthcare Conference

    Lexicon To Present At The 2015 Wedbush PacGrow Healthcare Conference

  5. UPDATE: AIG shares largely unmoved by earnings beat, buyback, dividend hike

    UPDATE: AIG shares largely unmoved by earnings beat, buyback, dividend hike

  6. UPDATE: Fitbit extends gains; Twitter sinks to all-time low

    UPDATE: Fitbit extends gains; Twitter sinks to all-time low

  7. How to Be Smarter About Risk Management

    Investors should only take risks that the market rewards--and that they can live with.

  8. How to Be Smarter About Risk Management

    Investors should only take risks that the market rewards--and that they can live with.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.